• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Stock

J&J talc bankruptcy stays in Texas despite ‘forum-shopping’ opposition

by October 10, 2024
written by October 10, 2024

By Dietrich Knauth

NEW YORK (Reuters) -A Johnson & Johnson (NYSE:JNJ) subsidiary can pursue its third attempt to resolve tens of thousands of lawsuits alleging its talc products caused cancer in a Texas bankruptcy court, a judge ruled on Thursday, allowing the company to avoid a venue that shot down its two previous efforts.

U.S. Bankruptcy Judge Christopher Lopez at a hearing in Houston rejected arguments raised by the U.S. Department of Justice’s Office of the U.S. Trustee, its bankruptcy watchdog, and attorneys representing some of the women with ovarian cancer who are opposed to the settlement.

They had argued that the case should be sent to a New Jersey bankruptcy court, which oversaw two previous bankruptcies meant to resolve the same talc lawsuits.

“I think this bankruptcy case is different,” Lopez said.

J&J faces lawsuits from more than 62,000 plaintiffs alleging its baby powder and other talc products were contaminated with asbestos and caused ovarian and other cancers. J&J has said the total number of claimants is even higher when including those who have not yet sued.

The company has said its products do not contain asbestos and do not cause cancer, and that bankruptcy is the best way to equitably compensate plaintiffs, who otherwise would wait years for their cases to be heard in a “lottery-like” tort system that often results in no recovery for plaintiffs.

Erik Haas, J&J’s worldwide vice president of litigation, said Lopez’s ruling would aid the company’s settlement efforts.

“Today’s decision is another step closer to full and final resolution of the talc litigation for the benefit of all stakeholders,” Haas said.

This post appeared first on investing.com
0 comment
0
FacebookTwitterPinterestEmail

previous post
US transportation chief says it is increasingly important to resolve Boeing strike
next post
Stellantis CEO Carlos Tavares to retire in 2026, company says

You may also like

Adani, Ambani news units sue OpenAI over copyright,...

March 13, 2026

China’s DeepSeek sets off AI market rout

March 13, 2026

BASF results down on impairments, restructuring

March 13, 2026

Nasdaq futures tumble as China’s AI push rattles...

March 13, 2026

European chipmakers slump as traders gauge DeepSeek AI...

March 13, 2026

Fuji Media, rocked by sexual misconduct allegations, says...

March 13, 2026

China Vanke’s CEO, chairman resign amid growing liquidity...

March 13, 2026

Italy’s MPS shares fall ahead of Mediobanca board...

March 13, 2026

UMG shares rally after new multi-year pact with...

March 13, 2026

British Land stock drops following stake sale

March 13, 2026
Sign up and get the scoop before anyone else—fresh updates, and secret deals, all wrapped up just for you. We're talking juicy tips, fun surprises, and invites to events you actually want to go to. Don’t just watch from the sidelines—jump in and be part of the magic!








    By signing up, you're cool with getting emails from us. Don’t worry — your info stays safe, sound, and strictly confidential. No spam, no funny business. Just the good stuff.

    Recent Posts

    • Build-A-Bear recalls roughly 36,000 Heart-Warming Hugs Bears

      May 2, 2026
    • Thermos recalls 8.2 million bottles after stoppers eject, causing injury and reported vision loss

      May 2, 2026
    • The Onion’s bid to take over Alex Jones’ Infowars is in limbo as new court battles emerge

      May 2, 2026
    • Republican state attorneys general join lawsuit to stop $6.2B local TV merger

      May 1, 2026

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (737)
    • Stock (6,426)

    Latest News

    • Build-A-Bear recalls roughly 36,000 Heart-Warming Hugs Bears
    • Thermos recalls 8.2 million bottles after stoppers eject, causing injury and reported vision loss

    Popular News

    • Bristol Myers faces renewed, $6.7 billion lawsuit over delayed cancer drug
    • GQG Partners’ stock plunges over 20% on US bribe, fraud charges against India’s Adani

    About The Significant deals

    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Copyright © 2026 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy